MS study points to the gut microbiome as a potential source of the disease

Multiple sclerosis is an autoimmune disease of the central nervous system, so it’s only natural to think that inflammatory molecules found in the brain are responsible for the disorder. But a new study showed they may not be the primary culprit.

Two types of interleukin-17 (IL-17) molecules specifically generated in the gut regulate its microbiome and seem to be critical drivers of MS, a research team led by the Johannes Gutenberg-University Mainz in Germany has reported.